Gene shifting: a novel therapy for mitochondrial myopathy.
about
Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failureMitochondriaMitochondrial DNA mutations in human diseaseMetabolic adaptations to repeated periods of contraction with reduced blood flow in canine skeletal muscle.Mitochondrial fragmentation in neurodegenerationRebuttal to Pak et al.: new data, chestnuts.Diagnosis and management of MELAS.Forward operation of adenine nucleotide translocase during F0F1-ATPase reversal: critical role of matrix substrate-level phosphorylation.Rhabdomyolysis: a review.Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonucleaseEpidemiology and treatment of mitochondrial disorders.Gene therapy for the treatment of mitochondrial DNA disorders.Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction.The pleiotropic effect of physical exercise on mitochondrial dynamics in aging skeletal muscle.Mitochondrial energetics and therapeutics.Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome.What can metabolic myopathies teach us about exercise physiology?Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A-->G mutation in bloodThe potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults.Mitochondrial DNA deletions in muscle satellite cells: implications for therapiesHow can we treat mitochondrial encephalomyopathies? Approaches to therapyMitochondrial-associated metabolic disorders: foundations, pathologies and recent progress.Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model.Mitochondrial DNA shifting in older adults following resistance exercise training.Development of pharmacological strategies for mitochondrial disorders.Altering the balance between healthy and mutated mitochondrial DNA.Exercise as a therapeutic strategy for primary mitochondrial cytopathies.Mitochondria, muscle health, and exercise with advancing age.Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases.Sustained AMPK activation improves muscle function in a mitochondrial myopathy mouse model by promoting muscle fiber regeneration.Compression Garments and Recovery from Eccentric Exercise: A (31)P-MRS Study.Mitochondrial myopathy and rhabdomyolysis associated with a novel nonsense mutation in the gene encoding cytochrome c oxidase subunit I.Resistance training in patients with single, large-scale deletions of mitochondrial DNA.Advances in the Treatment of MELAS Syndrome: Could Cognitive Rehabilitation Have a Role?Muscle Stem Cell and Physical Activity: What Point is the Debate at?
P2860
Q21144214-2A69F94F-EEB2-41AF-8471-6FEB0F41E1D4Q24671804-4FE52555-49A4-4FC1-B4FE-240477BA72D9Q24676881-5F89220C-4CAE-4582-926F-7D8846A2DCBDQ24813903-AC3CD510-61EC-48CD-8D35-461D42726C32Q28284588-CE61C304-1050-4540-8D62-32B509BDB368Q30824862-4292A578-F18F-44DE-BEA4-ECF7F0C3889CQ30956250-2C14F174-0D43-4C54-92CC-A139D0C13E91Q33919484-341D145A-85E1-4BB2-B038-95B417DDDA7BQ33957693-2C5E6333-CEDD-4EA1-8333-360985EE71C6Q34063452-BF2D08A9-8C31-410C-9345-F740BC5AF91BQ34386766-CE93E7F3-C33E-4FB6-A1BB-F4B87B0FD4ABQ34401459-31E73600-BBAA-457B-8BCD-2ACFE1A29912Q34452604-7C1959F9-4214-45F0-AFAE-015605430F75Q35471306-05861AD7-D696-49C2-B250-3C37EABB22FFQ35632864-60F9583F-C1B8-4C83-9FEE-3C377B9EC6BAQ36024220-6C606E35-6C8A-4189-8FF5-C16F980EAE62Q36444470-BEEE6F53-19FC-4C41-8DE7-9C6590EF72B6Q36719116-21855535-99A0-408A-B25E-66585E5C28A6Q37112576-F79D2EAE-EB85-4EF7-96FF-B4D6514EFF09Q37286993-EC4EACE7-E0B6-4831-B34F-1B971023D643Q37329530-C2E4F4C2-5688-41D4-B6FB-7DC05E954067Q37369860-9987F374-BCCD-4F2D-BDAC-8613E00085ECQ37407829-383C9E38-46AC-484E-B7E5-EF45842EAE80Q37485991-03A9627D-0354-42D9-82CB-E041661F00B5Q37686237-EA3C8EA6-A3C8-4008-96E7-87D47B7ABEF4Q37761076-D2601D23-D93E-4B22-9B06-AA926BAE19B4Q38227791-338116A0-8B7C-4FFB-B526-4119ED441EE9Q38453882-C314A182-AEE9-43A9-AF25-1503E6E845C5Q38824997-0A2C0625-A3A0-477F-80EA-A04BC5D03053Q39732168-9DC2F78A-82B6-4E05-881A-E4EE944715C8Q42920539-64F583E8-09A7-421B-B2E4-C3D85B1A80A9Q47837478-5A0DCAD5-CA49-47C8-8651-E63DABFB16E3Q48847004-4360301C-185B-4BD5-9F29-09CC13AF1ACDQ53343108-B1D21783-B6B9-4AF1-B24E-D10CBA586D4CQ55048133-4F0A8E73-1B96-4CCB-82A3-BBEF649397A3
P2860
Gene shifting: a novel therapy for mitochondrial myopathy.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Gene shifting: a novel therapy for mitochondrial myopathy.
@en
Gene shifting: a novel therapy for mitochondrial myopathy.
@nl
type
label
Gene shifting: a novel therapy for mitochondrial myopathy.
@en
Gene shifting: a novel therapy for mitochondrial myopathy.
@nl
prefLabel
Gene shifting: a novel therapy for mitochondrial myopathy.
@en
Gene shifting: a novel therapy for mitochondrial myopathy.
@nl
P2093
P356
P1476
Gene shifting: a novel therapy for mitochondrial myopathy.
@en
P2093
P304
P356
10.1093/HMG/8.6.1047
P577
1999-06-01T00:00:00Z